Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Sero-Strip HIV-1/2 efficacy demonstrated at CDC

April 12, 1996

Hema-Strip HIV-1/2 approved in Singapore

April 12, 1996

Dusa's ALA for detection of bladder cancer

April 12, 1996

Nuclear matrix proteins for detection of bladder cancer

April 12, 1996

TruQuant BR approved in U.S.

April 12, 1996

Patient enrollment completed for FS069 trial

April 12, 1996

Coronary artery diagnostic to enter clinical studies

April 5, 1996

Alzheimer's diagnostics introduced in U.S.

April 5, 1996

Molecular Biosystems, Shionogi agreement on the rocks

April 5, 1996

Ostex's NTx assay highly sensitive, specific in detecting bone turnover

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...